Clustering data with hclust algorithm for Large Scale HILIC Profiling of the Effects of Curcumin Supplementation of Older Adults: Relation to Vascular Function (Study ST000567)

HILIC POSITIVE ION MODE (Analysis AN000872)
MetaboliteStructureF1F2F3F4F5F6
17beta-Methylestra-1,3,5(10)-trien-3-olME1684100.300.510.470.85NA2.99
Phenanthrene-4,5-dicarboxylate + 3.291146ME1684570.180.710.280.73NA3.19
TG(8:0/8:0/8:0)ME1681930.950.530.801.42NA1.39
TG(16:0/14:0/16:1(9Z))[iso6]ME1682060.820.340.830.80NA2.31
Muramic acidME1684590.590.831.081.07NA1.52
TG(16:1(9Z)/14:0/18:2(9Z,12Z))[iso6]ME1682010.910.790.840.76NA1.72
CyperineME1682540.670.790.800.90NA1.91
TG(16:1(9Z)/14:0/16:1(9Z))[iso3]ME1681990.740.570.970.85NA1.96
4,5,6,7-Tetrahydroisoxazolo(5,4-c)pyridin-3-olME1684001.171.071.900.45NA0.40
27-HydroxycholesterolME1684541.561.210.620.60NA0.85
1,25-Dihydroxyvitamin D3-26,23-lactoneME1684581.221.680.310.52NA1.05
8Z,11Z,14Z-heptadecatrienoic acidME1684181.071.410.610.65NA1.15
Galabiosylceramide (d18:1/16:0)ME1682710.711.071.230.69NA1.32
?-AlanineME1683630.980.850.761.02NA1.39
Ceramide (d18:1/24:1(15Z))ME1684200.930.910.741.09NA1.34
1-Aminocyclohexanecarboxylic acidME1683911.190.781.080.87NA1.08
4^-O-MethylisoflavoneME1683330.871.130.860.88NA1.24
Otonecine + 7.909625ME1684521.011.090.820.79NA1.25
TG(18:1(9Z)/14:0/20:4(5Z,8Z,11Z,14Z))[iso6]ME1682020.891.180.960.70NA1.24
TG(18:2(9Z,12Z)/18:1(9Z)/18:3(6Z,9Z,12Z))[iso6]ME1684130.941.120.950.66NA1.29
D-Proline + 6.721675ME1684420.851.051.020.73NA1.35
TG(16:1(9Z)/16:0/18:3(9Z,12Z,15Z))[iso6]ME1682030.920.970.950.72NA1.43
CE(20:4)ME1682130.981.141.040.74NA1.06
DL-pipecolic acidME1683521.050.990.970.78NA1.19
TG(20:4(5Z,8Z,11Z,14Z)/14:0/18:3(9Z,12Z,15Z))[iso6]ME1681921.110.951.060.73NA1.12
PhytolME1682870.990.841.030.92NA1.25
TolmetinME1684090.980.791.031.00NA1.23
9-HydroxyphenanthreneME1683850.920.961.070.98NA1.10
BuprenorphineME1683800.930.871.031.05NA1.17
DG(22:4(7Z,10Z,13Z,16Z)/22:2(13Z,16Z)/0:0) + 1.1061205ME1682281.090.980.840.96NA1.10
MG(18:0/0:0/0:0)ME1682261.001.080.970.92NA1.00
7?-Hydroxy-3-oxo-4-cholestenoateME1682351.011.060.900.94NA1.07
PE(22:2(13Z,16Z)/15:0)ME1683370.981.001.010.93NA1.07
DG(22:4(7Z,10Z,13Z,16Z)/22:2(13Z,16Z)/0:0)ME1682271.001.040.970.92NA1.06
Docosanoic acidME1682890.981.030.960.94NA1.08
D-ProlineME1683540.980.940.910.89NA1.28
6-methyltetrahydropterinME1682641.000.960.890.95NA1.19
D-2-Amino-hexano-6-lactamME1682820.950.990.940.96NA1.16
Indoleacrylic acidME1683300.970.960.990.93NA1.15
L-prolyl-L-glycineME1683940.970.960.960.95NA1.16
DG(22:5(7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z)/0:0)ME1684190.910.901.060.82NA1.33
6-BenzylaminopurineME1682620.850.861.120.91NA1.30
TG(18:2(9Z,12Z)/16:0/22:5(7Z,10Z,13Z,16Z,19Z))[iso6]ME1684480.790.871.180.93NA1.29
6-endo-HydroxycineoleME1682160.870.910.941.17NA1.15
2-Oxo-7-methylthioheptanoic acidME1682630.700.941.081.11NA1.23
ChalepensinME1684530.821.021.010.97NA1.21
2E-methyl-glutaconic acidME1682691.021.410.631.06NA0.79
DebneyolME1684221.150.781.410.99NA0.71
4-Hydroxy-6-methylpyran-2-oneME1682721.180.841.221.07NA0.72
ADMAME1684441.070.861.281.14NA0.69
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:1(11Z))ME1683231.130.801.281.17NA0.66
19-Hydroxy-8-O-methyltetrangulolME1682701.191.021.291.10NA0.40
19-Hydroxy-8-O-methyltetrangulol + 2.978841ME1682741.211.021.281.05NA0.43
PE(20:5(5Z,8Z,11Z,14Z,17Z)/P-18:1(9Z))ME1683010.931.051.311.06NA0.68
PE(22:5(7Z,10Z,13Z,16Z,19Z)/P-18:1(11Z))ME1683000.991.091.191.01NA0.72
1-(beta-D-Ribofuranosyl)-1,4-dihydronicotinamideME1682791.041.051.201.18NA0.56
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/P-18:1(11Z))ME1682991.031.101.151.14NA0.59
2-Keto-6-aminocaproic acidME1682611.150.951.161.24NA0.51
9(S)-HpOTrEME1683411.030.931.171.29NA0.61
N1-AcetylspermidineME1684081.201.211.100.76NA0.66
GabapentinME1682421.201.130.920.71NA0.97
2S-amino-pentanoic acidME1682511.141.190.840.86NA0.90
Caproic acidME1682451.061.270.880.81NA0.91
3,7-Dimethyl-2E,6-octadienyl acetateME1682100.901.060.891.31NA0.86
7-MethylguanineME1684551.271.080.990.99NA0.62
Chenodeoxycholic acid sulfateME1683511.271.210.751.02NA0.67
IsopentenyladenineME1683961.161.200.971.02NA0.61
3-Dimethylallyl-4-hydroxyphenylpyruvateME1682771.111.180.871.10NA0.68
CycloleucineME1683401.131.260.871.10NA0.59
(S)-CoclaurineME1682331.071.270.911.04NA0.65
17-phenyl trinor Prostaglandin E2 serinol amideME1682320.970.881.101.15NA0.94
3-hydroxy-decanoic acidME1682521.111.090.861.07NA0.85
LamivudineME1681881.221.020.831.12NA0.78
PE(20:2(11Z,14Z)/18:2(9Z,12Z))ME1683061.051.191.040.85NA0.83
Astrasieversianin XVIME1682980.991.220.930.96NA0.86
BilirubinME1682151.031.180.871.03NA0.85
PI(20:3(5Z,8Z,11Z)/18:1(11Z))ME1682971.041.150.990.95NA0.84
HBAME1683721.091.120.950.96NA0.85
PiperidioneME1682501.091.110.950.93NA0.88
CarboxynorspermidineME1683821.061.080.960.95NA0.93
ValineME1683831.061.090.940.95NA0.93
4-OxoprolineME1683931.041.050.990.94NA0.96
(S)-ScoulerineME1683701.051.021.020.97NA0.93
MG(0:0/22:2(13Z,16Z)/0:0)ME1683131.001.141.021.14NA0.69
SphingosineME1684270.981.130.911.20NA0.77
2-MethylbutanalME1683351.091.060.991.01NA0.83
Otonecine + 7.3512187ME1683951.121.091.020.96NA0.79
NaltrexoneME1683691.081.141.021.00NA0.72
PE(20:3(5Z,8Z,11Z)/18:3(6Z,9Z,12Z))ME1683051.061.081.071.00NA0.77
PE(20:4(8Z,11Z,14Z,17Z)/P-18:1(9Z))ME1683021.030.951.071.19NA0.78
UridineME1682561.120.951.071.11NA0.75
DL-2-Aminooctanoic acidME1683891.071.021.101.11NA0.70
L-isoleucyl-L-prolineME1684061.081.031.111.06NA0.72
Phenanthrene-4,5-dicarboxylateME1682941.071.011.111.08NA0.73
5alpha-Cholestan-5alpha,6beta-diolME1682171.031.081.121.05NA0.72
PE(22:5(7Z,10Z,13Z,16Z,19Z)/P-18:1(11Z)) + 6.065796ME1683381.021.051.141.10NA0.70
TussilagineME1683531.061.021.051.12NA0.76
(+)-trans-alpha-IroneME1684071.091.041.011.08NA0.77
5-Methylthio-D-riboseME1682751.071.041.041.08NA0.76
Uridine + 2.294484ME1682651.071.041.051.05NA0.77
N(alpha)-t-Butoxycarbonyl-L-leucineME1683901.001.011.111.08NA0.83
Butyl acrylateME1683971.021.011.051.07NA0.86
CreatinineME1682911.021.021.041.06NA0.86
2^-O-MethyladenosineME1683461.061.031.031.04NA0.82
OtonecineME1683811.041.031.061.04NA0.82
3,4,5-Trimethoxycinnamic acidME1682550.961.051.371.42NA0.26
9S,11R,15S-trihydroxy-2,3-dinor-13E-prostaenoic acid-cyclo[8S,12R]ME1684260.901.001.261.46NA0.44
trans-ZeatinME1682660.961.021.241.31NA0.50
Coenzyme Q10ME1684110.981.131.041.50NA0.38
CaffeineME1682471.201.151.061.35NA0.22
Alpha-N-Phenylacetyl-L-glutamineME1683111.061.091.171.33NA0.37
(E)-2-Butenyl-4-methyl-threonineME1683991.061.181.251.18NA0.33
Concanamycin AME1683310.950.811.611.03NA0.68
4-DodecylphenolME1682180.830.891.311.37NA0.69
Neomenthyl acetateME1682050.840.901.291.36NA0.69
9,10-dihydroxy stearic acidME1682230.830.871.341.37NA0.68
Linoleic acidME1682200.850.891.321.36NA0.66
CarbarylME1684300.740.791.631.38NA0.61
cis-9,10-Epoxystearic acidME1682210.790.851.511.40NA0.57
5-(3-Pyridyl)-2-hydroxytetrahydrofuranME1684051.361.270.991.13NA0.17
delta-Guanidinovaleric acidME1682591.421.051.371.02NA0.09
L-IsoleucineME1684431.061.401.430.87NA0.20
PG(18:1(11Z)/20:3(5Z,8Z,11Z))ME1683320.991.291.390.82NA0.49
9S,12S,13S-trihydroxy-10E-octadecenoic acidME1682340.891.521.141.06NA0.35
Anthranilic acidME1683871.211.291.050.93NA0.44
ArtemisinME1683791.081.491.020.96NA0.38
DecylubiquinolME1683361.061.360.971.06NA0.50

Factors:

F1groups:Old-Curcumin | Time point:Post
F2groups:Old-Curcumin | Time point:Pre
F3groups:Old-Placebo | Time point:Post
F4groups:Old-Placebo | Time point:Pre
F5groups:young | Time point:Baseline
F6groups:young | Time point:Pre
Data matrix
  logo